Q4 2024 Earnings Call Transcript February 10, 2025 Inspire Medical Systems, Inc. beats earnings expectations. Reported EPS is ...

Medical technology company Inspire Medical Systems (NYSE:INSP) reported Q4 CY2024 results topping the market’s revenue expectations , with sales up 24.5% year on year to $239.7 million.

John Rondoni, the Chief Technology Officer of Inspire Medical Systems, Inc. (NYSE:INSP), recently executed a stock sale as part of a pre-established trading plan. On February 11, Rondoni sold 583 ...

Inspire Medical Systems (NYSE:INSP – Free Report) had its price target trimmed by Morgan Stanley from $230.00 to $220.00 in a research note issued to investors on Tuesday,Benzinga reports. The firm ...

Inspire Medical Systems (NYSE:INSP), known for its innovative devices that use neurostimulation to treat sleep apnea, announced impressive fourth-quarter results on Feb. 10. Earnings per share ...

Shares of NYSE INSP opened at $188.77 on Friday. The company has a 50 day moving average of $189.32 and a 200 day moving average of $186.43. Inspire Medical Systems has a twelve month low of $123. ...

Medical technology company Inspire Medical Systems (NYSE:INSP) reported Q4 CY2024 results topping the market’s revenue expectations , with sales up 24.5% year on year to $239.7 million. The company ...